3rd ESO Masterclass in Cancer Patient Advocacy

Scientific Co-ordinator: K. Redmond, CH
Steering Committee: V. Astratinei, RO - K. Benn, IT - S. Diler, TR - J. Geissler, DE - G. Henning, UK - T. Kolarova, BG - L. Makaroff, BE - K. Mastris, UK - K. Oliver, UK - A. Plate, DE - J. Taylor, UK - A. Stunt, UK - S. Wintrich, UK


The Masterclass in Cancer Patient Advocacy was launched by the European School of Oncology in 2014 to meet the educational needs of highly experienced cancer patient advocacy leaders who have limited opportunities to develop their advocacy skills, get updated on key cancer policy issues and explore how to improve their organisation’s performance.

This third edition of the Masterclass will bring together senior representatives of European and international cancer patient networks as well as a small number of future leaders.

To ensure that the Masterclass meets the needs of senior European cancer patient leaders, ESO has established a steering committee consisting of representatives from a number of the European cancer patient networks.

Selected EU/international cancer patient networks will be invited to send two delegates to the Masterclass (in addition to their representative on the Steering Committee).

LEARNING OBJECTIVES
• Help participants hone their advocacy and leadership skills
• Discuss ways of improving organizational impact and effectiveness
• Review state-of-the-art approaches to evidence based advocacy
• Provide participants with the opportunity to network and share experiences

MAIN TOPICS
• Lobbying for change
• Building effective and sustainable EU cancer patient networks (leadership, effectiveness, challenges of working with industry, Boards)
• Achieving sustainable access to cancer therapies
• Developing advocacy leadership skills (Communication, Persuasion & Influence, Coaching, Interpreting scientific data)
• Moving from anecdotal to evidence based advocacy

The Masterclass will be held in collaboration with the following cancer patient organisations:

• Childhood Cancer International (CCI)
• CML Advocates Network
• Europa Donna
• Europa Colon
• Europa Uomo 
• ECPC
• EURORDIS
• European Men’s Health Forum (EMHF)
• International Brain Tumour Alliance (IBTA)
• International Kidney Cancer Coalition
• INCA
• Lung Cancer Europe (LUCE)
• Lymphoma Coalition Europe
• MDS Alliance
• Melanoma Patient Network Europe
• MPNE Ocular/ Rare Melanoma Group
• Myeloma Patients Europe (MPE)
• Pancreatic Cancer Europe (PCE)
• Thyroid Cancer Alliance

ORGANISING SECRETARIAT
Corinne Hall
European School of Oncology (ESO)
Via Turati 29 - 20121 Milan, Italy
Tel: +39 02 85464522
Fax: +39 02 85464545
Email: chall@eso.net


PARTICIPATING ORGANISATIONS

MPNE Ocular/ MPNErare Network

ACKNOWLEDGMENTS
ESO is grateful to the following companies for supporting this event:
Amgen, AstraZeneca, Helsinn, Lilly, Merck KGaA, Novartis, Pfizer, Roche